| Name | Title | Contact Details |
|---|
DiagnosisONE Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Christian Care Ministry (CCM) is a non-profit that administers Medi-Share, a healthcare sharing program where Christians come together to share each other`s medical bills. CCM employs more than 700 individuals in Melbourne, FL, Colorado Springs, CO and remotely throughout the United States.
Quick Weight Loss Centers is a leading multi-state health and wellness company that provides highly differentiated weight loss management services. The company offers its program through both an in-center and digitally for clients not located in geographies with center locations.
Saint Peters Healthcare System, Inc. is a New Jersey nonprofit corporation sponsored by the Roman Catholic Diocese of Metuchen. The System consists of Saint Peters University Hospital, Saint Peters Health & Management Services Corporation and The Saint Peters Foundation. Saint Peters Healthcare System was formed in 2007 and reflects the expansive scope of health and wellness services we offer to our community. Our services are offered to all. We are a Catholic institution with a capital C and a small c. We draw inspiration from our religious heritage. Our care for others is universal, extending to those of other faiths and in some cases, of no faith whatsoever. Without question, the fact that ours is a faith-based healthcare delivery system is of primary significance. At Saint Peters Healthcare System, you will find leading-edge technology and an experienced staff. You will also find the trust and compassion that we have always been known for.
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.